Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07831122 |
| Title | Study of Belantamab Mafodotin, Cevostamab, Pomalidomide for RRMM Patients (MAPLE) |
| Acronym | MAPLE |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Canadian Myeloma Research Group |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Cross Cancer Institute | Edmonton | Alberta | T6G 1Z2 | Canada | Details | |
| QEII Health Sciences Centre | Halifax | Nova Scotia | B3H 2Y9 | Canada | Details | |
| London Health Sciences Centre | London | Ontario | N6A 5W9 | Canada | Details | |
| The Ottawa Hospital - General Hospital | Ottawa | Ontario | K1H 8L6 | Canada | Details | |
| UHN-Princess Margaret Cancer Centre | Toronto | Ontario | M5G 2M9 | Canada | Details | |
| Hospital Maisonneuve - Rosemont | Montreal | Quebec | H1T2M4 | Canada | Details | |
| McGill University Health Centre -MUHC | Montreal | Quebec | H4A 3J1 | Canada | Details |